← Back to Search

Anti-metabolites

Diagnostic (fluorine F-18 fluorothymidine PET) for Cancer

Phase 1
Waitlist Available
Led By Sarina A Piha-Paul
Research Sponsored by M.D. Anderson Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion; an average of 1 year.
Awards & highlights

Study Summary

This trial will test whether an imaging solution called FLT can help doctors better see changes in tumor growth in the body. Researchers want to see if FLT-PET scans can show an early response to chemotherapy.

Eligible Conditions
  • Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion; an average of 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion; an average of 1 year. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Response to Chemotherapy Shown in FLT-PET Scans

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diagnostic (fluorine F-18 fluorothymidine PET)Experimental Treatment3 Interventions
Patients undergo fluorine F-18 fluorothymidine PET at baseline, at day 6-8 of course 1, day 20 of course 2, and prior to day 1 of course 3.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Positron Emission Tomography
2008
Completed Phase 2
~2240
Fluorothymidine F-18
2003
Completed Phase 2
~180

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,667 Previous Clinical Trials
40,926,156 Total Patients Enrolled
M.D. Anderson Cancer CenterLead Sponsor
2,974 Previous Clinical Trials
1,789,386 Total Patients Enrolled
Sarina A Piha-PaulPrincipal InvestigatorM.D. Anderson Cancer Center
4 Previous Clinical Trials
440 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are new enrollees being accepted for this experiment?

"This particular research is not currently accepting new participants, as referenced on clinicaltrials.gov; it was first posted in April 2009 and last modified in June 2022. However, 147 other studies are presently enrolling patients."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies
2009. "FLT-PET in Predicting Response to Chemotherapy in Patients With Advanced Malignancies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00880074.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top